“Journalists are now talking about more people dying from vaccines than from the virus in Taiwan. It’s not clear to CNN, it’s good, too, “according to a report on Taiwan’s vaccination distributed by the social network Faebook.
A story about the course of the vaccination was shown on the air of NTD on independent television.
As written in the television presentation, NTD is a New York – based global television network founded by the Chinese who fled communism. They realized that independent media are very important to a free society. So they set up NTDs to provide the world with uncensored and accurate information.
During a NTD television report on social media, the presenter reviewed the data from the Taiwan Pharmacovigilance Information System reports.
This system is analogous in Europe „EudraVigilance“ and US VAERS operating systems.
Users can send reports of suspected side effects to a vaccine or medicine to them – the data entering these systems is not checked or sampled.
These reports are then carefully examined to find out the possible links between the medications and the side effects they may cause.
The fact that a suspected adverse reaction has been reported does not mean that the medicine actually caused the effects, because it could also be caused by a disease being treated, a new disease that the patient has had, or another medicine that the patient is taking.
System users are cautioned that these data cannot be attributed to vaccine exposure until they have been verified. These are only events that have occurred after vaccination, not since.
The report shows a screenshot of the Taiwan Pharmacovigilance System’s October 11 data this year, which shows that a total of 652 deaths from vaccination with the AstraZeneca manufacturer were reported between March 22 and October 8.
Another 184 such reports were recorded after vaccination with Moderna’s vaccine, between June 8 and October 8.
A total of 865 deaths have been reported in the Taiwanese system since the start of vaccination following vaccination with COVID-19, 499 of whom were over 75 years of age.
Taipei times, an independent Taiwanese news portal reported in June this year that none of the deaths recorded in the middle of the year after vaccination are associated with the vaccines because the recipients were older and seriously ill.
At present, the people of Taiwan already more than 27 million were injected. doses of COVID-19 vaccine.
Vaccines from Pfizer-BioNTech, Moderna and AstraZeneca approved in Europe and the United States are also available.
Vaccines were missing
In July this year, only 3 percent of people in Taiwan were vaccinated due to a lack of vaccines. population. Tuomet Lithuania has decided to donate 20 thousand. AstraZeneca manufacturer of vaccines.
It was decided to donate in mid-September another 235,900 doses of this manufacturer’s vaccine.
Matas Maldeikis, Head of the Seimas Parliamentary Relations Group with the Republic of China (Taiwan), in July 15min explained why every vaccine donated to this country is extremely important.
“Taiwan has coped well with the spread of coronavirus at the very beginning of the pandemic. Maybe that’s why there was no rush to order vaccines. At the same time, she began developing her own vaccine and hoped to be able to use it soon, but testing and approval took time.
Only about 3 percent were vaccinated in Taiwan at the start of the new outbreak. population.
China has taken advantage of the shortage of vaccines. It began offering Sinovac vaccines to Taiwan, which it considered its breakaway province.
However, the Taiwanese considered the proposal a “deadly kiss” and saw China’s aspirations to link Taiwan even more with China for such “generosity,” Maldeikis explained.
Mr Maldeikis said the deal, which had almost taken place between the Taiwanese government and Modernos in the United States, AstraZeneca in the United Kingdom and BioNTech in Germany, had been halted and eventually blocked by Chinese intervention.
Developed his own vaccine
The vaccine, manufactured by Taiwan’s Medigen Vaccine Biologics Corp., was approved for use in an emergency in July through an expedited procedure that was fiercely opposed by some Taiwanese doctors and scientists.
The active ingredient in Medigen, given as a two-dose injection, is a fragment of a viral protein that causes the body’s immune response to respond more quickly and effectively to the infection of a real pathogen.
One of the members of the Advisory Committee on Immunization resigned following the decision to grant approval under the new standard.
Critics say approval by the end of comprehensive clinical trials means that not enough information has been gathered on how effectively the vaccine protects against COVID-19 in real conditions, although the results of the initial studies could be encouraging.
Antibody levels in the blood have been shown to correlate with protection against COVID-19 disease, but researchers do not yet know how much protection they provide.
Medigen will have to submit the collected efficacy data within one year of the vaccine being approved, the supervisory authorities said.
According to them, the information provided by the manufacturers at the time of approval of the product showed that the vaccine allows the body to produce 3.4%. more virus-neutralizing antibodies than AstraZeneca.
The publication was prepared in 15 minutes in collaboration with Facebook, which aims to stop the spread of misleading news on the social network. More about the program and its rules – here.
Source: 15min.lt – suprasti akimirksniu | RSS by www.15min.lt.
*The article has been translated based on the content of 15min.lt – suprasti akimirksniu | RSS by www.15min.lt. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!